1494 related articles for article (PubMed ID: 28962668)
1. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
2. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
4. Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR.
Stürup AE; Hjorthøj C; Albert N; Dolmer S; Birk M; Ebdrup BH; Eplov LF; Jensen H; Vernal DL; Speyer H; Mors O; Nordentoft M
Front Psychiatry; 2022; 13():910703. PubMed ID: 35935409
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction).
Moncrieff J; Lewis G; Freemantle N; Johnson S; Barnes TRE; Morant N; Pinfold V; Hunter R; Kent LJ; Smith R; Darton K; Horne R; Crellin NE; Cooper RE; Marston L; Priebe S
BMJ Open; 2019 Nov; 9(11):e030912. PubMed ID: 31780589
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
[TBL] [Abstract][Full Text] [Related]
7. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
8. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders.
Andrade C
J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767930
[TBL] [Abstract][Full Text] [Related]
10. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of discontinuation from antipsychotic maintenance following first-episode schizophrenia and related disorders: a 10 year follow-up of a randomised, double-blind trial.
Hui CLM; Honer WG; Lee EHM; Chang WC; Chan SKW; Chen ESM; Pang EPF; Lui SSY; Chung DWS; Yeung WS; Ng RMK; Lo WTL; Jones PB; Sham P; Chen EYH
Lancet Psychiatry; 2018 May; 5(5):432-442. PubMed ID: 29551618
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
Moncrieff J; Crellin N; Stansfeld J; Cooper R; Marston L; Freemantle N; Lewis G; Hunter R; Johnson S; Barnes T; Morant N; Pinfold V; Smith R; Kent L; Darton K; Long M; Horowitz M; Horne R; Vickerstaff V; Jha M; Priebe S
Lancet Psychiatry; 2023 Nov; 10(11):848-859. PubMed ID: 37778356
[TBL] [Abstract][Full Text] [Related]
13. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome.
Wunderink L; Nienhuis FJ; Sytema S; Slooff CJ; Knegtering R; Wiersma D
J Clin Psychiatry; 2007 May; 68(5):654-61. PubMed ID: 17503973
[TBL] [Abstract][Full Text] [Related]
14. The Momentum trial: the efficacy of using a smartphone application to promote patient activation and support shared decision making in people with a diagnosis of schizophrenia in outpatient treatment settings: a randomized controlled single-blind trial.
Vitger T; Austin SF; Petersen L; Tønder ES; Nordentoft M; Korsbek L
BMC Psychiatry; 2019 Jun; 19(1):185. PubMed ID: 31208376
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.
Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L
Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
Huhn M; Leucht C; Rothe P; Dold M; Heres S; Bornschein S; Schneider-Axmann T; Hasan A; Leucht S
Eur Arch Psychiatry Clin Neurosci; 2021 Mar; 271(2):293-302. PubMed ID: 32062728
[TBL] [Abstract][Full Text] [Related]
18. Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design.
Nasib LG; Sommer IE; Winter-van Rossum I; de Vries J; Gangadin SS; Oomen PP; Judge G; Blom RE; Luykx JJ; van Beveren NJM; Veen ND; Kroken RA; Johnsen EL
Trials; 2020 Jun; 21(1):492. PubMed ID: 32513294
[TBL] [Abstract][Full Text] [Related]
19. The effect of a mindfulness-based intervention in cognitive functions and psychological well-being applied as an early intervention in schizophrenia and high-risk mental state in a Chilean sample: study protocol for a randomized controlled trial.
Langer ÁI; Schmidt C; Mayol R; Díaz M; Lecaros J; Krogh E; Pardow A; Vergara C; Vergara G; Pérez-Herrera B; Villar MJ; Maturana A; Gaspar PA
Trials; 2017 May; 18(1):233. PubMed ID: 28545578
[TBL] [Abstract][Full Text] [Related]
20. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
